IQVIA Rises 1.1% on Light Trading and Mixed Institutional Activity

IQVIA (NYSE: IQV) saw a 1.10% stock rise on March 13, 2026, despite light trading volume and mixed institutional activity, with some large investors decreasing holdings while smaller firms increased theirs. Analysts largely maintain a “Buy” rating, projecting a potential 38% upside, affirming confidence in IQVIA’s strategic position and strong financial performance. The company’s updated 2026 guidance and consistent revenue growth underscore its leadership in healthcare analytics, balancing short-term valuation concerns with long-term optimism.